| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027129A1 Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof |
| 04/19/2001 | WO2001027127A1 Tamoxifen and tamoxifen analogue glycosides and uses thereof |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027097A1 Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
| 04/19/2001 | WO2001027090A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027082A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS |
| 04/19/2001 | WO2001027081A1 6-position substituted indoline, production and use thereof as a medicament |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001027070A1 Use of carbonylamino derivatives against cns disorders |
| 04/19/2001 | WO2001026737A2 Treatment of excessive bone or cartilage loss with an activator of ror alpha and assay for identifying such activator |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026667A1 Tenocyte compositions and production and uses thereof |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/19/2001 | WO2001026640A2 Treatment of osteoporosis |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2001001963A8 A method for the improvement of transport across adaptable semi-permeable barriers |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999056785A3 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2392209A1 M-substituted benzoic acid derivatives having integrin .alpha.v.beta.3 antagonistic activity |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386821A1 3-aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092728A2 Biologically digestable complex of orthosilicic acid in a solid, stable and concentrated form and proces for its preparation |
| 04/18/2001 | EP1092723A2 Bisphosphonic acid derivative and compound thereof labelled with radioactive nuclide |
| 04/18/2001 | EP1092436A1 Tenocyte compositions, preparation and use |
| 04/18/2001 | EP1092431A2 Lasofoxifene compositions |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091774A1 Bone cement with antimicrobial peptides |
| 04/18/2001 | EP1091759A2 Composition for the induction of apoptosis in target cells |
| 04/18/2001 | EP1091738A1 BICYCLIC sPLA 2 INHIBITORS |
| 04/18/2001 | EP1091730A1 Utilization of growth factors for the production of medicaments |
| 04/18/2001 | EP1091726A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis |
| 04/18/2001 | EP0915823B1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 04/18/2001 | EP0723544B1 ALKOXY ALKYL CARBAMATES OF IMIDAZO[1,2-a]PYRIDINES |
| 04/18/2001 | CN1291993A Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 04/18/2001 | CN1291979A Novel pyridazine derivatives and drugs containing same as active ingredient |
| 04/18/2001 | CN1291978A Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/18/2001 | CN1291609A Method of preparing 5-lipoxidase inhibitor possessing different heterocyclic ring system |
| 04/18/2001 | CN1291501A Chinese-medicinal capsule for treating osteonecrosis |
| 04/18/2001 | CN1291498A Ointment for treating spinal hyperosteogeny |
| 04/18/2001 | CN1291496A Plaster 'Gucixiao' and its preparing process |
| 04/18/2001 | CN1064538C Weibikang capsule |
| 04/17/2001 | US6218537 Process for making pyridyl and pyrimidine substituted imidazole compounds |
| 04/17/2001 | US6218430 Vitamin D3 mimics |
| 04/17/2001 | US6218418 Therapy of cell proliferative disorders associated with an altered cell dependent kinase activity by administering amino pyrazole derivative to mammal |
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218387 Vitronectin receptor anatagonists, their preparation and their use |
| 04/17/2001 | US6218159 Amino acid sequence; bacteriostats; bactericides; antibiotics; diagnosis of infections; drug screening |
| 04/17/2001 | US6218136 Methods of the identification of pharmaceutically active compounds |
| 04/17/2001 | CA2157003C Hormone replacement therapy |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025435A2 In vivo treatment of joint disease using interleukin-1 receptor antagonists |
| 04/12/2001 | WO2001025404A1 Methods for inhibiting osteoclast formation or methods for inhibiting bone resorption |
| 04/12/2001 | WO2001025402A1 Isolation of precursor cells and their use for tissue repair |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025229A1 Amide compounds |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025186A1 Novel ltb4 antagonist, method for the production thereof and its use as a medicament |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024821A1 Nell-1 enhanced bone mineralization |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024797A1 Integrin receptor antagonists |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |